Effect of proteases and protease inhibitors on adenylate cyclase activity in rat cerebral cortical membranes.
D000262:Adenylyl Cyclases / Q000378:metabolism*; D000818:Animals; D002462:Cell Membrane / Q000201:enzymology; D002540:Cerebral Cortex / Q000201:enzymology*; D004789:Enzyme Activation; D005459:Fluorides / Q000494:pharmacology; D005732:Gangliosides / Q000494:pharmacology; D006165:Guanylyl Imidodiphosphate / Q000494:pharmacology; D007700:Kinetics; D008297:Male; D009638:Norepinephrine / Q000494:pharmacology; D010447:Peptide Hydrolases / Q000494:pharmacology*; D011480:Protease Inhibitors / Q000494:pharmacology*; D051381:Rats
D005732:Gangliosides; D011480:Protease Inhibitors; D006165:Guanylyl Imidodiphosphate; D010447:Peptide Hydrolases; D000262:Adenylyl Cyclases; D005459:Fluorides; D009638:Norepinephrine